Medicare Compliance & Reimbursement
Don't Forget The GS Modifier For High-Hemoglobin ESRD Patients
The Centers for Medicare & Medicaid Services (CMS) will crack down on coverage for erythropoiesis stimulating agents (ESAs) used to treat anemia in patients who receive dialysis for end-stage renal disease (ESRD). Since CMS last updated its coverage, the Food & Drug Administration issued a "black box" warning, saying that large doses of ESAs are risky for ESRD patients with hemoglobin levels above 12 g/dL.
Effective next January, Medicare will continue to pay the same for ESAs for patients with hemoglobin of between 10 and 12 g/dL. But for patients whose levels rise above 13 g/dL, you should reduce the patient's dosage by 25 percent and append the GS modifier. This modifier shows that the provider has reduced the patient's ESA dosage in response to the hemoglobin/ hematocrit level. And if the hemoglobin is above 13 for more than three months, the provider should reduce dosages by 50 percent.
CMS also says it won't pay for dosages of epoetin alpha (Epogen) over 400,000 IUs per month, or higher doses of darbepoetin alpha (Aranesp) than 1200 mcg per month.
Medicare Compliance & Reimbursement
- PHYSICIANS:
Once Again, Congress Opts For A Short-Term Fix To Your Pay Crisis
Urge your senator to support House version of health bill.
When it comes to Medicare legislation, [...] - REIMBURSEMENT:
Steer Clear Of Bundled Codes With 99143-99150
Look for systemic conditions that support moderate sedation.
So your Medicare carrier (or private payor) has [...] - MODIFIERS:
Don't Forget The GS Modifier For High-Hemoglobin ESRD Patients
Check out these sticky new guidelines for ESAs.
The Centers for Medicare & Medicaid Services (CMS) [...] - PART B:
Why Nominal Payments Don't Create Any Obligation For You
Exercise your right to request a reasonable patient payment plan -- here's how.
Myth: If a [...] - CODING:
Take 5 To Get A Jump On How ICD-9 2008 Will Affect You
Use these tactics to help your physician's documentation line up with new specific coding options.
You [...] - BILLING:
Throw Out Your Unlisted Codes For Electronic Brachytherapy
Find out what code you can use for this cancer-treatment system.
If your physician has been [...] - COMPLIANCE:
OIG Wants To Squeeze Your Drug Payments Further
Doxorubic and Interferon are at the top of the hit list.
Warning: Your already low payments [...] - INDUSTRY NOTES:
Rural Counties Could Reap More Cash From Geographic Payment Fix
Plus: Doctor gets one-year sentence for false billing.
Physicians who are getting shortchanged by the current [...]
